← Back to Vaccine Database

ALVAC-CMV (vCP260)

Live attenuated vaccine · VDDBV0084

Target & Classification

CMVCytomegalovirus
Live attenuated vaccine
Cytomegalovirus Infections
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT00353977 Phase 2Cytomegalovirus Infections